• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Reportlinker Adds Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017


News provided by

Reportlinker

Apr 21, 2011, 06:06 ET

Share this article

Share this article


NEW YORK, April 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

http://www.reportlinker.com/p0484484/Traumatic-Brain-Injury-TBI-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html

Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, "Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Traumatic Brain Injury Therapeutics market. The report identifies the key trends shaping and driving the global Traumatic Brain Injury Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Traumatic Brain Injury Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Traumatic Brain Injury Therapeutics market. Its Scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Traumatic Brain Injury Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Traumatic Brain Injury Therapeutics market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Traumatic Brain Injury Therapeutics market.

- Analysis of key recent licensing and partnership agreements in Traumatic Brain Injury Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Traumatic Brain Injury Therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Traumatic Brain Injury Therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global Traumatic Brain Injury Therapeutics market landscape? – Identify, understand and capitalize.

Table of Contents

1 Table of contents

1 Table of contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 TBI Therapeutics: Introduction 6

2.1 Disease Overview 6

2.2 Epidemiology 9

2.3 Etiology 9

2.4 Signs and Symptoms 10

2.5 Diagnosis 10

2.6 Treatment and management Pattern 12

2.7 GlobalData Pipeline Report Guidance 14

3 TBI Therapeutics: Market Characterization 15

3.1 Overview 15

3.2 TBI Therapeutics Market Size (2005–2010) – Global 15

3.3 TBI Therapeutics Market Forecast (2010–2017) – Global 16

3.4 TBI Therapeutics Market Size (2005–2010) – The US 17

3.5 TBI Therapeutics Market Forecast (2010–2017) – The US 18

3.6 TBI Therapeutics Market Size (2005–2010) – France 19

3.7 TBI Therapeutics Market Forecast (2010–2017) – France 20

3.8 TBI Therapeutics Market Size (2005–2010) – Germany 21

3.9 TBI Therapeutics Market Forecast (2010-2017) – Germany 22

3.10 TBI Therapeutics Market Size (2005–2010) – Italy 23

3.11 TBI Therapeutics Market Forecast (2010–2017) – Italy 24

3.12 TBI Therapeutics Market Size (2005–2010) – Spain 25

3.13 TBI Therapeutics Market Forecast (2010–2017) – Spain 26

3.14 TBI Therapeutics Market Size (2005–2010) – The UK 27

3.15 TBI Therapeutics Market Forecast (2010–2017) – The UK 28

3.16 TBI Therapeutics Market Size (2005–2010) – Japan 29

3.17 TBI Therapeutics Market Forecast (2010–2017) – Japan 30

3.18 Drivers and Barriers for TBI Therapeutics Market 31

3.18.1 Drivers for the TBI Therapeutics Market 31

3.18.2 Barriers for the TBI Therapeutics Market 31

3.19 Opportunity and Unmet Need Analysis 32

3.19.1 Opportunity and Unmet Need in the TBI Market, 2010 32

3.20 Key Takeaway 32

4 TBI Therapeutics: Competitive Assessment 33

4.1 Overview 33

4.2 Strategic Competitor Assessment 33

4.3 Product Profile for the Major Marketed Products in the TBI Therapeutics 34

4.3.1 NovoSeven 34

4.3.2 Mannitol 35

4.4 Key Takeaway 35

5 TBI Therapeutics: Pipeline Assessment 36

5.1 Overview 36

5.2 Strategic Pipeline Assessment 36

5.3 TBI Therapeutics Pipeline – Pipeline by Phases of Development 36

5.3.1 TBI Therapeutics – Phase III Pipeline 37

5.3.2 TBI Therapeutics –Phase II Pipeline 37

5.3.3 TBI Therapeutics –Phase I Pipeline 38

5.3.4 TBI Therapeutics – Preclinical Phase 38

5.3.5 TBI Therapeutics – Discovery Pipeline 38

5.4 Technology Trends Analytic Framework 39

5.5 TBI Therapeutics – Clinical Pipeline by Mechanism of Action 41

5.6 TBI Therapeutics – Promising Drugs under Clinical Development 42

5.7 Molecule Profiling for Promising Drugs under Clinical development 42

5.7.1 BHR-100 42

5.7.2 NHOO1 43

5.8 Key Takeaway 43

6 TBI Therapeutics: Clinical Trials Mapping 44

6.1 Clinical Trials by Region/ Country 44

6.2 Clinical Trials by Phase 45

6.3 Clinical Trials by Trial Status 46

6.4 Top 10 companies participating in Therapeutics Clinical Trials 47

6.5 Prominent Sponsors 48

7 TBI Therapeutics: Strategic Assessment 50

7.1 Key Events Impacting the Future Market 50

7.2 Implications for Future Market Competition 51

8 TBI Therapeutics: Future Players 52

8.1 Introduction 52

8.2 Company Profiles 52

8.2.1 BHR Pharma, LLC 52

8.2.2 Vasopharm GmbH 53

8.2.3 NeuroHealing Pharmaceuticals Inc. 54

9 TBI Therapeutics: Licensing and Partnership Deals 55

10 TBI Therapeutics: Appendix 56

10.1 Market Definitions 56

10.2 Abbreviations 56

10.3 Research Methodology 57

10.3.1 Coverage 57

10.3.2 Secondary Research 57

10.3.3 Forecasting 58

10.3.4 Primary Research 61

10.3.5 Expert Panel Validation 61

10.4 Contact Us 61

10.5 Disclaimer 61

10.6 Bibliography 62

List of Tables

1.1 List of Tables

Table 1: Common Types Of TBI 8

Table 2: Management Of TBI Based on Severity of Injury 11

Table 3: TBI Therapeutics Market, Global, Revenue, ($m), 2005–2010 15

Table 4: TBI Therapeutics Market, Global, Forecast ($m), 2010–2017 16

Table 5: TBI Therapeutics Market, The US, Revenue ($m), 2005–2010 17

Table 6: TBI Therapeutics Market, The US, Forecast ($m), 2010–2017 18

Table 7: TBI Therapeutics Market, France, Revenue ($m), 2005–2010 19

Table 8: TBI Therapeutics Market, France, Forecasts ($m), 2010–2017 20

Table 9: TBI Therapeutics Market, Germany, Revenue ($m), 2005–2010 21

Table 10: TBI Therapeutics Market, Germany, Forecast ($m), 2010–2017 22

Table 11: TBI Therapeutics Market, Italy, Revenue ($m), 2005–2010 23

Table 12: TBI Therapeutics Market, Italy, Forecast ($m), 2010–2017 24

Table 13: TBI Therapeutics Market, Spain, Revenue ($m), 2005–2010 25

Table 14: TBI Therapeutics Market, Spain, Forecast ($m), 2010–2017 26

Table 15: TBI Therapeutics Market, The UK, Revenue ($m), 2005–2010 27

Table 16: TBI Therapeutics Market, The UK, Forecast ($m), 2010–2017 28

Table 17: TBI Therapeutics Market, Japan, Revenue ($m), 2005–2010 29

Table 18: TBI Therapeutics Market, Japan, Forecast ($m), 2010–2017 30

Table 19: TBI Therapeutics – Phase III Clinical Pipeline, 2011 37

Table 20: TBI Therapeutics – Phase II Clinical Pipeline, 2011 37

Table 21: TBI Therapeutics – Phase I Clinical Pipeline, 2011 38

Table 22: TBI Therapeutics – Preclinical Pipeline, 2011 38

Table 23: TBI Therapeutics – Discovery Pipeline, 2011 38

Table 24: TBI Therapeutics – Most Promising Drugs Under Clinical Development, 2011 42

Table 25: TBI Therapeutics Market, Clinical Trials by Region/ Country 44

Table 26: TBI Therapeutics Market, Clinical Trials by Phase, 2011 45

Table 27: TBI Therapeutics Market, Clinical Trials by Trial Status, 2011 46

Table 28: TBI Therapeutics Market, Clinical Trials by Top 10 Companies Participating in Therapeutics Clinical Trials, 2011 47

Table 29: TBI Therapeutics Market – Clinical Trials by Overall Sponsors, 2011 48

Table 30: TBI Therapeutics Market – Clinical Trials by Prominent Sponsors, 2011 49

Table 31: BHR Pharma – CNS Pipeline Products, 2011 53

Table 32: Vasopharm GmbH – CNS Pipeline Products, 2011 53

Table 33: Vasopharm GmbH, Deals, 2009 53

Table 34: NeuroHealing Pharmaceuticals – CNS Pipeline Products, 2011 54

Table 35: TBI Therapeutics Market, Global, Deals, 2004-2006 55

List of Figures

1.2 List of Figures

Figure 1: TBI Classification on the Basis of Severity Of Injury 6

Figure 2: Effects of TBI 7

Figure 3: TBI Therapeutics Market – Causes 9

Figure 4: TBI Continuum of Care 12

Figure 5: TBI Therapeutics Market, Global, Revenue ($m), 2005–2010 15

Figure 6: TBI Therapeutics Market, Global, Forecast ($bn), 2010–2017 16

Figure 7: TBI Therapeutics Market, The US, Revenue ($m), 2005–2010 17

Figure 8: TBI Therapeutics Market, The US, Forecast ($m), 2010–2017 18

Figure 9: TBI Therapeutics Market, France, Revenue ($m), 2005–2010 19

Figure 10: TBI Therapeutics Market, France, Forecast ($m), 2010–2017 20

Figure 11: TBI Therapeutics Market, Germany, Revenue ($m), 2005–2010 21

Figure 12: TBI Therapeutics Market, Germany, Forecast ($m), 2010–2017 22

Figure 13: TBI Therapeutics Market, Italy, Revenue ($m), 2005–2010 23

Figure 14: TBI Therapeutics Market, Italy, Forecast ($m), 2010–2017 24

Figure 15: TBI Therapeutics Market, Spain, Revenue ($m), 2005–2010 25

Figure 16: TBI Therapeutics Market, Spain, Forecast ($m), 2010–2017 26

Figure 17: TBI Therapeutics Market, The UK, Revenue ($m), 2005–2010 27

Figure 18: TBI Therapeutics Market, The UK, Forecast ($m), 2010–2017 28

Figure 19: TBI Therapeutics Market, Japan, Revenue ($m), 2005–2010 29

Figure 20: TBI Therapeutics Market, Japan, Forecast ($m), 2010–2017 30

Figure 21: Opportunity and Unmet Need in the TBI Therapeutics Market, 2010 32

Figure 22: Strategic Competitor Assessment of the Marketed Products for TBI, 2011 33

Figure 23: TBI Therapeutics Pipeline by Phase of Development, 2011 36

Figure 24: Technology Trends Analytic Framework of the TBI Therapeutics Pipeline, 2011 39

Figure 25: Technology Trends Analytic Framework of the TBI Therapeutics pipeline- Description, 2011 40

Figure 26: TBI Therapeutics, Clinical Pipeline by Mechanism of Action, 2011 41

Figure 27: TBI Therapeutics Market – Clinical Trials by Region/Country, 2011 44

Figure 28: TBI Therapeutics Market – Clinical Pipeline by Phase, 2011 45

Figure 29: TBI Therapeutics Market – Clinical Trials by Trial Status, 2011 46

Figure 30: TBI Therapeutics Market – Clinical Trials by Top 10 Companies Participating in Therapeutics Clinical Trials, 2011 47

Figure 31: TBI Therapeutics Market – Clinical Trials by Overall Sponsors, 2011 48

Figure 32: TBI Therapeutics Market – Clinical Trials by Prominent Sponsors, 2011 49

Figure 33: TBI Therapeutics, Global, Key Events Impacting the Future Market 50

Figure 34: Implications for Future Market Competition in the TBI Therapeutics Market, 2011 51

Figure 35: TBI Therapeutics Market – Clinical Pipeline by Company, 2011 52

Figure 36: GlobalData Market Forecasting Model 60

To order this report:

: Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.